Annual report and financial statements for the period ended 31 December 2024
OCTOPUS FUTURE GENERATIONS VCT PLC Annual report and financial statements for the period ended 31 December 2024 Octopus Future Generations VCT plc (‘Future Generations VCT’ or the ‘Company’) is backing businesses that aim to address some of society’s biggest challenges, providing an opportunity for investors to share in the growth of ambitious, purpose‑driven companies. The Company is managed by Octopus AIF Management Limited (the ‘Manager’), which has delegated investment management to Octopus Investments Limited (‘Octopus’ or ‘Portfolio Manager’) via its investment team Octopus Ventures. Chair’s statement I am pleased to present the financial report and audited accounts for the Company for the 18 months to 31 December 2024. I would like to welcome all of our new shareholders to the Company. Future Generations VCT invests in exciting early-stage companies which aspire to address current environmental and societal issues. In 2023, the Board reviewed and approved a proposal to move the Company’s year end from 30 June to 31 December. As a result, shareholders are receiving this annual report covering an extended 18-month period and will thereafter receive a half-year report as at June, and annual report and audited financial statements for the years ending December thereafter. The NAV per share at 31 December 2024 was 88.8p, which represents a net decrease of 5.5p per share from 30 June 2023. In the 18 months to 31 December 2024, we utilised £10.1 million of our cash resources, including £8.2 million which was invested into 16 new and follow‑on opportunities. The cash balance of £20.1 million (excluding cash awaiting allotment) as at 31 December 2024 represents 42% of net assets at that date. The loss made in the period to 31 December 2024 was £2.9 million. This decline is reflective of some company specific performance challenges and the difficult funding conditions in the early-stage space which have led to downward movements in some valuations. Given the Company is still a relatively young VCT, many of its portfolio companies are at the beginning of their journey and will likely require further funding to succeed, so it is to be expected to see under performance or even failures before any growth in value of companies which are ultimately successful. The decline is also accentuated by the running costs of the Company exceeding returns from investments, which is to be anticipated at this stage. We look forward to deploying further capital into attractive new investment opportunities, and we ultimately intend the profile of the Company to comprise 80% to 90% in VCT qualifying investments and 10% to 20% in permitted non-VCT qualifying investments or cash. Fundraise We raised £3.6 million in the fundraise which closed on 31 October 2024. The 2023/2024 VCT fundraise market was highly competitive, ranking as the third highest on record with £882 million raised. In this environment, newer VCTs such as ours faced challenges in raising funds, as we compete with more established funds. On 3 February 2025, to further support the Company’s growth, the Board launched an initial offer to raise up to £5 million. The offer closed for new applications on 1 April 2025 for the 2024/2025 tax year having successfully raised £5.0 million. As investors will be aware, the intention is to invest in businesses which meet one of three key themes, which we hope will demonstrate excellent investment prospects as well as having the potential to transform the world we live in for the better. VCT status In November 2023, a ten-year extension was announced to the ‘sunset clause’ (a retirement date for the VCT scheme), meaning that VCT tax reliefs will be available until 5 April 2035. This extension passed through Parliament in February 2024 and on 3 September 2024 His Majesty’s Treasury brought the extension into effect through The Finance Act 2024. Board of Directors As announced in the half-yearly report to 31 December 2023, Emma Davies announced her retirement from the Board of Directors with effect from 31 March 2024 and Ajay Chowdhury was appointed with effect from 1 March 2024 and was elected by shareholders at the Annual General Meeting (AGM) held in December. We are already benefiting from his extensive experience in the early-stage venture ecosystem. All the other Directors have indicated their willingness to remain on the Board and will be seeking re-election at the AGM. Portfolio Manager In September 2024, Octopus Titan VCT PLC, a fund which the Company has co-invested alongside to date, announced a review of strategy, due to the ongoing performance issues it has faced. This review (which benefits from independent external advice) is ongoing, and when concluded, the results will be shared with the Board of the Company and via any public announcements that the Board of Octopus Titan VCT PLC may make. During this period, the investment team has prioritised much of its resource towards those portfolio companies which they believe have the potential to drive the greatest returns. This has affected your Company’s investment rate into new opportunities. In the meantime, there have been a significant number of leavers from the broader Octopus Ventures team which invests capital from both the Company and other funds under management. Simon King, Octopus’ Lead Fund Manager for Future Generations, has unfortunately resigned to pursue a new opportunity after 13 years with Octopus. He will continue to take an active role as Lead Fund Manager of the Company until late summer. I would like to take this opportunity to thank Simon for his contribution and to wish him well for the future. We will provide you with updates in due course regarding his potential successor. Erin Platts was appointed as new Chief Executive Officer (CEO) of Octopus Ventures in January 2025. Previously, she was CEO of HSBC Innovation Banking UK, formerly Silicon Valley Bank UK and worked at the heart of the UK and European tech ecosystem. Erin will be looking to scale the Octopus Ventures business, including ensuring there is appropriate investment and portfolio management resource to support the ongoing success of the Company. AGM The AGM will take place on 4 June 2025 from 10am and will be held at 33 Holborn, London EC1N 2HT. Full details of the business to be conducted at the AGM are given in the Notice of the AGM. We will have a Portfolio Manager’s update at the AGM, supported by a filmed update from the Portfolio Manager which will be available on the website at www.octopusinvestments.com/futuregenvct/. Shareholders’ views are important, and the Board encourages shareholders to vote on the resolutions within the Notice of the AGM using the proxy form, or electronically at www.investorcentre.co.uk/eproxy. The Board has carefully considered the business to be approved at the AGM and recommends shareholders to vote in favour of all the resolutions being proposed, as the Board will be doing. Outlook In the 18-month reporting period, the sharpest decline in NAV was seen in the first half of 2024 with a 7.1% drop. This was reflective of some of the portfolio companies struggling to scale, secure customer wins and successfully fundraise, meaning they were not achieving the milestones set at the time the Company invested. With companies not able to prove their business models, we will unfortunately see some fail. The Board is mindful that such performance is not an unusual outcome for a VCT at this stage of its investment life cycle, with any failures likely preceding valuation growth which is usually expected once the portfolio matures. The portfolio has been operating in a volatile macro environment since the Company launched and global geo-political and economic pressures continue to hamper some of their growth plans. However, we are satisfied to see a stabilisation in the NAV, with the portfolio showing a positive return in the six months from June to December 2024. The Mergers and Acquisitions (M&A) environment has started to thaw with startups experiencing the highest annual M&A transaction levels since 2019¹. We are delighted to have been able to realise the Company’s first full and partial exits in the reporting period. These exits within just three years of launch we hope provide validation of Future Generations VCT’s investment strategy, demonstrating the ability of Octopus to identify and back high-potential companies while delivering early returns to the VCT and brings confidence that it is well positioned to generate long-term, sustainable value for shareholders. The long-term target is to pay an annual dividend of 5% of the NAV. However, given the expected holding period of target portfolio companies and restrictions imposed on VCTs, it is very unlikely that the Company will be able to pay dividends before 2026. During this time, any growth in value will increase the net asset value of the Company. Dividends are likely to be generated from successful exits, so the Company is unlikely to pay significant dividends until more portfolio companies have time to mature and realisations are secured. I would like to conclude by thanking both my Board colleagues and the Octopus team on behalf of all shareholders for their hard work. The Board’s long-term view of early-stage venture capital remains positive, and I am looking forward to seeing what 2025 brings for your Company. Helen Sinclair Chair 1 https://carta.com/uk/en/data/state-of-private-markets-q4-2024/#key-trends Portfolio Manager’s review At Octopus, our focus is on managing your investments and providing investors with clear and transparent communication. Our annual and half-yearly updates are designed to keep you informed about the progress of your investment. Focus on Future Generations VCT’s performance The NAV per share at 31 December 2024 was 88.8p, which represents a decrease in NAV of 5.5p per share versus a NAV of 94.3p per share as at 30 June 2023. The Company invests in three key areas that we believe demonstrate excellent investment prospects and have potential to transform our world for the better. Below is a breakdown of the 36 investments held as at 31 December 2024, showing the proportion and value of the portfolio in each investment theme: Proportion by number of portfolio companies in each theme Revitalising healthcare: 53% Empowering people: 28% Building a sustainable planet: 19% Value of the portfolio in each theme Revitalising healthcare: £13.3m Empowering people: £8.0m Building a sustainable planet: £5.5m The decline in valuation over the 18-month period has been in large part driven by the downward valuation movements across 11 companies which saw a collective decrease in valuation of £7.9 million. The businesses which contributed most significantly to this were Tympa Health, Pear Bio and Elo Health. Tympa Health over‑invested in growth and had to make significant cost cuts and changes to senior management whilst running a fundraise process. It has successfully concluded a further investment round, but at a reduced valuation and the Company’s shareholding now sits behind a large preference stack, meaning that other investors get paid back first before the Company would see any returns. Pear Bio also had to significantly reduce its cash burn but has limited runway and needs to further fundraise, so the valuation has been reduced to reflect the risk to its future. Elo Health struggled to find a market fit and execute on the investment thesis, so to extend its cash runway it had to raise an investment round at a reduced valuation. These three valuation movements account for 86% of the total decline in the reporting period. The total investment cost of these three companies was £7 million. Octopus Ventures believes that some of the companies which have seen decreased valuations in the 18 months have the potential to overcome the issues they face and get their growth plans back on track. We will continue to work with them to help them realise their ambitions. In some cases, if a company is achieving its performance milestones, the support offered could include further funding, to ensure a business has the capital it needs to execute on its strategy. At this early stage of the Company’s life cycle, it is to be anticipated that failures will likely precede valuation growth, which takes longer as the portfolio companies must achieve their agreed milestones and mature. Conversely, 12 companies saw an increase in unrealised valuation in the period, delivering a collective increase in valuation of £4.4 million. These valuation increases reflect businesses which have successfully concluded further funding rounds, grown revenues or met certain important milestones. Notable strong performers in the portfolio include Apheris and Manual, both of which have shown impressive capital efficient growth. These strong performers demonstrate that there are opportunities available for companies to scale. The interest on Future Generation’s uninvested cash reserves was £1.4 million in the 18 months to 31 December 2024 (30 June 2023: gain of £0.4 million), driven by returns on money market funds. The Board’s objective for these investments is to generate sufficient returns through the cycle to cover costs, at limited risk to capital. Disposals In September 2024, as part of a Series A funding round, Octopus sold a portion of the Company’s shares in Neat. Then in November, Pluxee (a global leader in employee benefits) acquired Cobee. The two exits combined offer the Company a return of 1.5x, including contingent deferred proceeds. Overview of investments The Company completed 16 investments in the 18 months to 31 December 2024 (comprising a total of £8.2 million) and 4 further investments after the reporting date totalling £2.4 million. More information on some of these businesses can be found below: A selection of our completed investments Revitalising Healthcare Pencil Biosciences is a gene editing technology platform. Awell Health automates routine clinical tasks, synchronising data between systems and driving seamless coordination between care teams and patients. Cellvoyant is an artificial intelligence (AI) first biotechnology company creating novel stem cell-based therapies for chronic diseases. Manual provides easy access to advice and medical support for diagnosis, custom treatment plans and holistic care to induce long-term behaviour change. Nanosyrinx has developed a targeted biologic therapeutic delivery platform (a nano-syringe). Empowering people Correcto is an AI writing and grammar tool for the Spanish language. Remofirst is an Employer of Record (EOR) and compliance platform that allows companies to hire and pay employees globally. Swiipr has developed a digital payments platform specifically for the airline industry. Building a sustainable planet Metris Energy has created a platform that allows landlords of multi-unit buildings to monetise modular renewable energy projects through a single billing platform to charge tenants. Drift is designing sailing vessels and routing algorithms required to capture deep water wind energy and convert it into onboard hydrogen gas for transportation back to shore using a fully integrated desalination, electrolysis and storage system. Q&A Q. How do you value a portfolio company? A. Future Generations VCT’s unquoted portfolio companies are valued in accordance with UK Generally Accepted Accounting Practice (UK GAAP) accounting standards and the International Private Equity and Venture Capital (IPEV) valuation guidelines. This means we value the portfolio at fair value, with all companies being valued at least twice yearly, for our half-year (June) and annual accounts (December). Q. What do you mean by ‘fair value’? A. When we say fair value, we mean the price we expect people would be willing to buy or sell an asset for, assuming they understand the asset and market conditions, are knowledgeable parties, act independently, and that the transaction is carried out under the normal course of business (i.e. is not rushed and proper marketing has taken place). Q. Who values the portfolio, what is the process and what oversight is there to make sure this is right? A. The Octopus Investment Managers involved with the portfolio companies, either in the capacity of a Director or observer on the board, or the primary contact, will provide commentary including, but not limited to, recent developments with the portfolio and the wider market in which they operate, progress towards milestones, management team changes, board dynamics and technical progress. This is combined with the latest available financial accounts and budget provided by the portfolio company which will be summarised into Key Performance Indicators (KPIs). From this information, a member of the separate Valuations team drafts the initial proposal. This will highlight any material changes, key asset level assumptions used and KPIs, and discuss portfolio company performance as well as the rationale underpinning the selected valuation methodology. A peer review exercise then takes place, where the proposals are challenged and reviewed. The peer reviewer is an investment professional from the Fund Manager (typically the Lead Fund Manager) who has not been involved in preparing the valuations. This will then be reviewed and approved by the Octopus Valuations Committee which comprises individuals with appropriate expertise and experience in valuations. Those individuals are not involved in the investment decisions and as such can independently review and challenge. The Future Generations VCT Board will then meet to discuss them in detail, revise as necessary and ultimately approve them. There are also more valuation checkpoints throughout the year in advance of allotments and other share-related transactions, which means that the portfolio’s valuation is reviewed to ensure NAV is fairly represented prior to these corporate actions. As part of our continuous improvement processes, we periodically review the actual realised value of our investments compared to their last holding value and refine our valuation methodologies accordingly. This, combined with the high proportion of valuations that are based on the terms of further funding rounds led by new external investors, firmly underpins the robustness of the valuation process. Valuations The table illustrates the split of valuation methodology (shown as a percentage of portfolio value and number of companies). ‘External price’ includes valuations based on funding rounds that typically completed in the last 18 months to the period end or shortly after the period end, and exits of companies where terms have been agreed with an acquirer. ‘Multiples’ is predominantly used for valuations that are based on a multiple of revenues for portfolio companies. Where there is uncertainty around the potential outcomes available to a company, a probability weighted ‘scenario analysis’ is considered.
| Valuation methodology | By value | By number of companies |
| Multiples | 18% | 3 |
| External price | 44% | 12 |
| Scenario analysis | 14% | 7 |
| Milestone analysis | 24% | 10 |
| Write-off | — | 4 |
| Portfolio company | Investment cost | Valuation at 31 December 2024 | Investment Theme |
| 1. HelloSelf Limited | £2.6m | £2.6m | Revitalising healthcare |
| 2. Remofirst, Inc | £1.2m | £1.7m | Empowering people |
| 3. Infinitopes Ltd | £1.6m | £1.6m | Revitalising healthcare |
| 4. Neat SAS | £0.6m | £1.5m | Building a sustainable planet |
| 5. TYTN Ltd (t/a TitanML) | £0.5m | £1.5m | Building a sustainable planet |
| 6. Apheris AI GmbH | £1.5m | £1.5m | Empowering people |
| 7. Menwell Limited (t/a Manual) | £0.9m | £1.5m | Revitalising healthcare |
| 8. Mr & Mrs Oliver Ltd (t/a Skin + Me) | £1.0m | £1.4m | Revitalising healthcare |
| 9. Intrinsic Semiconductor Technologies Ltd | £0.9m | £1.2m | Empowering people |
| 10. CoMind Technologies Ltd | £0.8m | £1.0m | Revitalising healthcare |
| Initial investment date: | January 2023 |
| Investment cost: | £2.6m |
| (2023: £2.6m) | |
| Valuation: | £2.6m |
| (2023: £2.6m) | |
| Last submitted accounts: | 31 March 2024 |
| Turnover: | Not available2 (2023: Not available2) |
| Profit/(loss) before tax: | Not available2 |
| (2023: Not available2) | |
| Net assets: | £(15.5)m |
| (2023: £(9.8)m) | |
| Valuation methodology: | Calibration |
| Initial investment date: | February 2024 |
| Investment cost: | £1.2m |
| (2023: n/a) | |
| Valuation: | £1.7m |
| (2023: n/a) | |
| Last submitted accounts: | Not available2 |
| Turnover: | Not available2 |
| (2023: Not available2) | |
| Profit/(loss) before tax | Not available2 |
| (2023: Not available2) | |
| Net assets: | Not available2 |
| (2023: Not available2) | |
| Valuation methodology: | Last Round |
| Initial investment date: | December 2022 |
| Investment cost: | £1.6m |
| (2023: £1.6m) | |
| Valuation: | £1.6m |
| (2023: £1.6m) | |
| Last submitted accounts: | 31 December 2023 |
| Turnover: | Not available2 |
| (2023: Not available2) | |
| Profit/(loss) before tax | Not available2 |
| (2023: Not available2) | |
| Net assets: | £9.3m |
| (2023: £8.1m) | |
| Valuation methodology: | Last Round |
| Initial investment date: | November 2022 |
| Investment cost: | £0.6m |
| (2023: £0.8m) | |
| Valuation: | £1.5m |
| (2023: £0.8m) | |
| Last submitted accounts: | Not available2 |
| Turnover: | Not available2 |
| (2023: Not available2) | |
| Profit/(loss) before tax: | Not available2 |
| (2023: Not available2) | |
| Net assets: | Not available2 |
| (2023: Not available2) | |
| Valuation methodology: | Last round |
| Initial investment date: | February 2023 |
| Investment cost: | £0.5m |
| (2023: £0.5m) | |
| Valuation: | £1.5m |
| (2023: £0.5m) | |
| Last submitted accounts: | 30 April 2024 |
| Turnover: | Not available2 |
| (2023: Not available2) | |
| Profit/(loss) before tax: | Not available2 |
| (2023: Not available2) | |
| Net assets: | £1.5m |
| (2023: £2.0m) | |
| Valuation methodology: | Last Round |
| Initial investment date: | November 2022 |
| Investment cost: | £1.5m |
| (2023: £1.2m) | |
| Valuation: | £1.5m |
| (2023: £1.2m) | |
| Last submitted accounts: | Not available2 |
| Turnover: | Not available2 |
| (2023: Not available2) | |
| Profit/(loss) before tax: | Not available2 |
| (2023: Not available2) | |
| Net assets: | Not available2 |
| (2023: Not available2) | |
| Valuation methodology: | Last round |
| Initial investment date: | May 2024 |
| Investment cost: | £0.9m (2023: n/a) |
| Valuation: | £1.5m |
| (2023: n/a) | |
| Last submitted accounts: | 31 December 2023 |
| Turnover: | £54.7m (2023: £22.4m) |
| Profit/(loss) before tax: | £(7.9)m (2023: £(10.6)m) |
| Net assets: | £11.8m (2023: £8.0m) |
| Valuation methodology: | Last round |
| Initial investment date: | December 2022 |
| Investment cost: | £1.0m |
| (2023: £1.0m) | |
| Valuation: | £1.4m |
| (2023: £1.3m) | |
| Last submitted accounts: | 31 August 2023 |
| Turnover: | £28.7m |
| (2023: £14.3m) | |
| Profit/(loss) before tax: | £1.8m |
| (2023: £(3.3)m) | |
| Net assets: | £12.8m |
| (2023: £(0.7)m) | |
| Valuation methodology: | Revenue Multiple |
| Initial investment date: | December 2023 |
| Investment cost: | £0.9m |
| (2023: n/a) | |
| Valuation: | £1.2m |
| (2023: n/a) | |
| Last submitted group accounts: | 31 December 2023 |
| Turnover: | Not available2 (2023: Not available2) |
| Profit/(loss) before tax: | Not available2 (2023: Not available2) |
| Consolidated net assets: | £4.0m |
| (2023: £5.5m) | |
| Valuation methodology: | Scenario Analysis |
| Initial investment date: | November 2023 |
| Investment cost: | £0.8m |
| (2023: n/a) | |
| Valuation: | £1.0m |
| (2023: n/a) | |
| Last submitted group accounts: | 31 December 2023 |
| Turnover: | Not available2 (2023: Not available2) |
| Profit/(loss) before tax: | Not available2 (2023: Not available2) |
| Net assets: | £17.1m |
| (2023: £4.1m) | |
| Valuation methodology: | Milestone Analysis |
| Risk | Mitigation | Change |
| Investment performance: | ||
| The focus of Future Generations VCT investments is into early-stage, unquoted, small and medium‑sized VCT qualifying companies which, by their nature, entail a higher level of risk and shorter cash runway than investments in larger quoted companies. | Octopus has significant experience of investing in early-stage unquoted companies, and appropriate due diligence is undertaken on every new investment. A member of the Octopus Ventures team is appointed to the board of a portfolio company using a risk-based approach, considering the size of the company within the Future Generations VCT portfolio and the engagement levels of other investors. This arrangement, in conjunction with its Portfolio Talent team’s active involvement, allows Future Generations VCT to play a prominent role in a portfolio company’s ongoing development and strategy. | Increased exposures reflected in the previous period remain unchanged due to the difficult macro environment and challenging trading conditions for some portfolio companies continuing. |
| Risk | Mitigation | Change |
| VCT qualifying status: | ||
| Future Generations VCT is required at all times to observe the conditions for the maintenance of approved VCT status. The loss of such approval could lead to Future Generations VCT and its investors losing access to the various tax benefits associated with VCT status and investment. | Octopus tracks Future Generations VCT’s qualifying status throughout the period, and reviews this at key points, including at the point of investment and realisation. This status is reported to the Board at each Board meeting. The Future Generations VCT Board has also engaged external independent advisers to undertake an independent VCT status monitoring role. | VCT status monitoring by independent advisers continues to reduce the risk of an issue causing a loss of VCT status. |
| Risk | Mitigation | Change |
| Loss of key people: | ||
| The loss of key investment staff by the Portfolio Manager could lead to poor fund management and/or performance due to lack of continuity or understanding of Future Generations VCT. | The Portfolio Manager has a broad team experienced in and focused on early-stage investing. This mitigates the risk of any one individual with the required skill set and knowledge of venture capital investing, and the portfolio specifically, leaving. Key investment staff are also incentivised via the performance incentive fee. | The increase is attributed to the departure of key personnel from the Octopus Ventures team and risk exposure reflects a reduction in performance fees potentially increasing attrition. |
| Risk | Mitigation | Change |
| Operational: | ||
| The Future Generations VCT Board is reliant on the Portfolio Manager to manage investments effectively, and manage the services of a number of third parties, in particular the registrar, depositary and tax advisers. A failure of the systems or controls at Octopus or third‑party providers could lead to an inability to provide accurate reporting and accounting and to ensure adherence to VCT rules. | The Future Generations VCT Board reviews the system of internal controls, both financial and non-financial, operated by Octopus (to the extent the latter are relevant to Future Generations VCT's internal controls). These include controls designed to make sure that Future Generations VCT assets are safeguarded and that proper accounting records are maintained. | No overall change in risk exposure on balance. |
| Risk | Mitigation | Change |
| Information security: | ||
| A loss of key data could result in a data breach and fines. The Future Generations VCT Board is reliant on Octopus and third parties to take appropriate measures to prevent a loss of confidential customer information. | Annual due diligence is conducted on third parties which includes a review of their controls for information security. Octopus has a dedicated Information Security team and a third party is engaged to provide continual protection in this area. A security framework is in place to help prevent malicious events. The appropriateness of mitigants in place are continuously reassessed to adapt to new risk exposures, such as those posed by artificial intelligence. | No overall change on balance, although cyber threat remains a significant risk area faced by all providers. |
| Risk | Mitigation | Change |
| Economic: | ||
| Events such as an economic recession, movement in interest rates, inflation and rising living costs could adversely affect some smaller companies’ valuations, as they may be more vulnerable to changes in trading conditions of the sectors in which they operate. This could result in a reduction in the value of Future Generations VCT assets. | Future Generations VCT aims to invest in a diverse portfolio of companies, across a range of sectors, which helps to mitigate against the impact on any one sector. Future Generations VCT also maintains adequate liquidity to make sure that it can continue to provide follow‑on investment to those portfolio companies which require it and which are supported by the individual investment case. | Increased exposures reflected in the previous periods remain as economic uncertainty persists through high inflation, high interest rates and other economic factors. |
| Risk | Mitigation | Change |
| Legislative: | ||
| A change to the VCT regulations could adversely impact Future Generations VCT by restricting the companies Future Generations VCT can invest in under its current strategy. Similarly, changes to VCT tax reliefs for investors could make VCTs less attractive and impact Future Generations VCT’s ability to raise further funds. | The Portfolio Manager engages with HM Treasury and industry bodies to demonstrate the positive benefits of VCTs in terms of growing early-stage companies, creating jobs and increasing tax revenue, and to help shape any change to VCT legislation. | Risk exposure has reduced following the extension of the sunset clause to 2035 being agreed. |
| Risk | Mitigation | Change |
| Liquidity: | ||
| The risk that Future Generations VCT’s available cash will not be sufficient to meet its financial obligations. Future Generations VCT invests into smaller unquoted companies, which are inherently illiquid as there is no readily available market for these shares. Therefore, these may be difficult to realise for their fair market value at short notice. | Future Generations VCT’s liquidity risk is managed on a continuing basis by Octopus in accordance with policies and procedures agreed by the Board. Future Generations VCT’s overall liquidity risks are monitored on a quarterly basis by the Board, with frequent budgeting and close monitoring of available cash resources. Future Generations VCT maintains sufficient investments in cash and readily realisable securities to meet its financial obligations. At 31 December 2024, these resources were valued at £20,084,000. | Risk exposures continue to increase, reflecting the potential knock-on effects of economic uncertainty, impacting fundraising and increasing the risk of disposal failure. |
| 18 months to 31 December 2024 | Year to 30 June 2023 | ||||||
| Revenue | Capital | Total | Revenue | Capital | Total | ||
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | ||
| Gain on disposal of fixed asset investments | — | 1,382 | 1,382 | — | — | — | |
| Net loss on valuation of fixed asset investments | — | (3,564) | (3,564) | — | (6) | (6) | |
| Investment management fee | (345) | (1,035) | (1,380) | (174) | (522) | (696) | |
| Investment income | 1,427 | — | 1,427 | 424 | — | 424 | |
| Other expenses | (759) | — | (759) | (500) | — | (500) | |
| Earnings/(loss) before tax | 323 | (3,217) | (2,894) | (250) | (528) | (778) | |
| Tax | — | — | — | — | — | — | |
| Earnings/(loss) after tax | 323 | (3,217) | (2,894) | (250) | (528) | (778) | |
| Earnings/(loss) per share – basic and diluted | 0.6p | (6.3)p | (5.7)p | (0.6)p | (1.3)p | (1.9)p | |
| As at 31 December 2024 | As at 30 June 2023 | |||||
| £’000 | £’000 | £’000 | £’000 | |||
| Fixed asset investments | 26,769 | 24,895 | ||||
| Current assets: | ||||||
| Debtors | 1,166 | 379 | ||||
| Applications cash1 | 100 | 370 | ||||
| Cash at bank | 112 | 152 | ||||
| Money market funds | 19,972 | 20,140 | ||||
| 21,350 | 21,041 | |||||
| Creditors: amounts falling due within one year | (196) | (518) | ||||
| Net current assets | 21,154 | 20,523 | ||||
| Net assets | 47,923 | 45,418 | ||||
| Share capital | 54 | 48 | ||||
| Share premium | 51,854 | 46,461 | ||||
| Capital reserve realised | (328) | (640) | ||||
| Capital reserve unrealised | (3,526) | 3 | ||||
| Revenue reserve | (131) | (454) | ||||
| Total equity shareholders’ funds | 47,923 | 45,418 | ||||
| NAV per share | 88.8p | 94.3p | ||||
| Share capital £’000 | Share premium £’000 | Capital reserve realised1 £’000 | Capital reserve unrealised £’000 | Revenue reserve1 £’000 | Total £’000 | |
| As at 1 July 2023 | 48 | 46,461 | (640) | 3 | (454) | 45,418 |
| Comprehensive income for the period: | ||||||
| Management fees allocated as capital expenditure | — | — | (1,035) | — | — | (1,035) |
| Current year gain on disposal of fixed asset investments | — | — | 1,382 | — | — | 1,382 |
| Net loss on fair value of fixed asset investments | — | — | — | (3,564) | — | (3,564) |
| Gain after tax | — | — | — | — | 323 | 323 |
| Total comprehensive loss for the period | — | — | 347 | (3,564) | 323 | (2,894) |
| Contributions by and distributions to owners: | ||||||
| Share issue | 6 | 5,506 | — | — | — | 5,512 |
| Share issue costs | — | (113) | — | — | — | (113) |
| Total contributions by and distributions to owners | 6 | 5,393 | — | — | — | 5,399 |
| Other movements: | ||||||
| Prior year fixed asset loss unrealised | — | — | (35) | 35 | — | — |
| Total other movements | — | — | (35) | 35 | — | — |
| Balance as at 31 December 2024 | 54 | 51,854 | (328) | (3,526) | (131) | 47,923 |
| Share capital £’000 | Share premium £’000 | Capital reserve realised1 £’000 | Capital reserve unrealised £’000 | Revenue reserve1 £’000 | Total £’000 | |
| As at 1 July 2022 | 33 | 31,572 | (118) | 9 | (204) | 31,292 |
| Comprehensive income for the period: | ||||||
| Management fees allocated as capital expenditure | — | — | (522) | — | — | (522) |
| Net loss on fair value of fixed asset investments | — | — | — | (6) | — | (6) |
| Loss after tax | — | — | — | — | (250) | (250) |
| Total comprehensive loss for the period | — | — | (522) | (6) | (250) | (778) |
| Contributions by and distributions to owners: | ||||||
| Shares issued | 15 | 15,164 | — | — | — | 15,179 |
| Share issue costs | — | (275) | — | — | — | (275) |
| Total contributions by and distributions to owners | 15 | 14,889 | — | — | — | 14,904 |
| Balance as at 30 June 2023 | 48 | 46,461 | (640) | 3 | (454) | 45,418 |
| 18 months to 31 December | Year to 30 June | ||
| 2024 | 2023 | ||
| £’000 | £’000 | ||
| Cash flows from operating activities | |||
| Loss before tax1 | (2,894) | (778) | |
| Decrease/(increase) in debtors | 173 | (325) | |
| Decrease in creditors | (52) | (103) | |
| Gain on disposal of fixed assets | (1,382) | — | |
| Loss on valuation of fixed asset investments | 3,564 | 6 | |
| Outflow from operating activities | (591) | (1,200) | |
| Cash flows from investing activities | |||
| Purchase of fixed asset investments | (8,162) | (23,238) | |
| Sale of fixed asset investments | 3,146 | — | |
| Outflow from investing activities | (5,016) | (23,238) | |
| Cash flows from financing activities | |||
| Movement in applications account | (270) | (1,544) | |
| Proceeds from share issues | 5,512 | 15,179 | |
| Share issue costs | (113) | (275) | |
| Inflow from financing activities | 5,129 | 13,360 | |
| Decrease in cash and cash equivalents | (478) | (11,079) | |
| Opening cash and cash equivalents | 20,662 | 31,741 | |
| Closing cash and cash equivalents | 20,184 | 20,662 | |
| Cash and cash equivalents comprise | |||
| Cash at bank | 112 | 152 | |
| Money market funds | 19,972 | 20,140 | |
| Applications cash | 100 | 370 | |
| Closing cash and cash equivalents | 20,184 | 20,662 |
| 18 months to | ||
| 31 December 2024 | 30 June 2023 | |
| £’000 | £’000 | |
| Money market funds | 1,427 | 424 |
| Total investment income | 1,427 | 424 |
| 18 months to 31 December 2024 | Year to 30 June 2023 | |||||
| Revenue | Capital | Total | Revenue | Capital | Total | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| Investment | ||||||
| management fee | 345 | 1,035 | 1,380 | 174 | 522 | 696 |
| Total | 345 | 1,035 | 1,380 | 174 | 522 | 696 |
| 18 months to | Year to | |
| 31 December | 30 June | |
| 2024 | 2023 | |
| £’000 | £’000 | |
| NISA fees | 213 | 122 |
| Directors' remuneration1 | 157 | 77 |
| Audit fees2 | 78 | 63 |
| Directors and Officers (D&O) insurance | 74 | 15 |
| Depositary fees | 62 | 57 |
| Listing fees | 46 | 58 |
| Registrars fees | 28 | 21 |
| Director recruitment & expenses | 27 | — |
| Report and account fees | 26 | 38 |
| Other fees | 48 | 49 |
| Total | 759 | 500 |
| 18 months to | Year to | |
| 31 December | 30 June | |
| 2024 | 2023 | |
| £’000 | £’000 | |
| Loss on ordinary activities before tax | (2,894) | (778) |
| Current tax at 25% (2023: 20.5%) | (724) | (159) |
| Effects of: | ||
| Non-taxable income | (357) | — |
| Non-taxable capital gains | 546 | 1 |
| Non-deductible expenses | 1 | — |
| Excess management expenses on which deferred tax not recognised | 534 | 193 |
| Tax rate differences1 | — | (35) |
| Total current tax charge | — | — |
| 18 months to 31 December 2024 | Year to 30 June 2023 | |||||
| Revenue | Capital | Total | Revenue | Capital | Total | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| Earnings/(loss) attributable to Ordinary shareholders (£’000) | 323 | (3,217) | (2,894) | (250) | (528) | (778) |
| Earnings/(loss) per Ordinary share (p) | 0.6 | (6.3) | (5.7) | (0.6) | (1.3) | (1.9) |
| 31 December | 30 June | |
| 2024 | 2023 | |
| Net assets (£’000) | 47,923 | 45,418 |
| Shares in issue | 53,941,104 | 48,138,337 |
| NAV per share (p) | 88.8 | 94.3 |